The cover is an artistic depiction of the results described in the paper by Brunetto et al., the findings highlight a link between HER2 and CDC25A that positively modulates HER2-targeted therapeutic response, suggesting that, in HER2 positive breast cancer patients, CDC25A overexpression affects trastuzumab sensitivity.

© Neoplasia 2013